Characteristic | Initial treatment with SSRI (N = 5,012) |
---|---|
Gender; n (%) | |
Female | 3,267 (65.2) |
Male | 1,745 (34.8) |
Age; mean (SD) | 41.9 (15.3) |
Age distribution in years; n (%) | |
18–24 | 773 (15.4) |
25–34 | 948 (18.9) |
35–44 | 1,164 (23.2) |
45–54 | 1,110 (22.1) |
55–64 | 722 (14.4) |
65+ | 295 (5.9) |
Plan type; n (%) | |
CDHP | 174 (3.5) |
COMP | 224 (4.5) |
EPO | 78 (1.6) |
HMO | 1,233 (24.8) |
Non-capitated POS | 449 (9.0) |
POS with capitation | 9 (0.2) |
PPO | 2,696 (54.3) |
Missing/unknown | 99 (2.0) |
Region; n (%) | |
Northeast | 718 (14.3) |
North central | 1,324 (26.4) |
South | 1,431 (28.6) |
West | 1,526 (30.4) |
Unknown | 13 (0.3) |
Charlson comorbidity index; mean (SD), median | 0.5 (1.1), 0.0 |
Chronic disease score; mean (SD), median | 2.1 (2.5), 1.0 |